SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Imax Corp. – ‘10-Q’ for 9/30/22 – ‘EX-31.1’

On:  Monday, 10/31/22, at 5:01pm ET   ·   For:  9/30/22   ·   Accession #:  950170-22-20630   ·   File #:  1-35066

Previous ‘10-Q’:  ‘10-Q’ on 7/29/22 for 6/30/22   ·   Next:  ‘10-Q’ on 4/27/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 4/25/24 for 3/31/24   ·   2 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/31/22  Imax Corp.                        10-Q        9/30/22  124:35M                                    Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   9.03M 
 2: EX-10.1     Material Contract                                   HTML    109K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     43K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     43K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     38K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     39K 
12: R1          Document and Entity Information                     HTML     92K 
13: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    153K 
14: R3          Condensed Consolidated Balance Sheets               HTML     42K 
                (Parenthetical)                                                  
15: R4          Condensed Consolidated Statements of Operations     HTML    143K 
                (Unaudited)                                                      
16: R5          Condensed Consolidated Statements of Comprehensive  HTML     92K 
                Loss (Unaudited)                                                 
17: R6          Condensed Consolidated Statements of Cash Flows     HTML    141K 
                (Unaudited)                                                      
18: R7          Condensed Consolidated Statements of Shareholders'  HTML    155K 
                Equity (Unaudited)                                               
19: R8          Basis of Presentation                               HTML     75K 
20: R9          Impact of COVID-19 Pandemic                         HTML     41K 
21: R10         Recently Issued Accounting Standards                HTML     53K 
22: R11         Acquisition                                         HTML     89K 
23: R12         Receivables                                         HTML   1.18M 
24: R13         Lease Arrangements                                  HTML    297K 
25: R14         Inventories                                         HTML     69K 
26: R15         Borrowings                                          HTML    160K 
27: R16         Commitments, Contingencies and Guarantees           HTML     67K 
28: R17         Condensed Consolidated Statements of Operations     HTML    163K 
                Supplemental Information                                         
29: R18         Condensed Consolidated Statements of Cash Flows     HTML    228K 
                Supplemental Information                                         
30: R19         Income Taxes                                        HTML    255K 
31: R20         Capital Stock and Reserves                          HTML    443K 
32: R21         Revenue from Contracts with Customers               HTML    965K 
33: R22         Segment Reporting                                   HTML    423K 
34: R23         Employees Pension and Postretirement Benefits       HTML    103K 
35: R24         Financial Instruments                               HTML    332K 
36: R25         Non-Controlling Interests                           HTML     71K 
37: R26         Basis of Presentation (Policies)                    HTML    172K 
38: R27         Basis of Presentation (Tables)                      HTML     56K 
39: R28         Acquisition (Tables)                                HTML     80K 
40: R29         Receivables (Tables)                                HTML   1.15M 
41: R30         Lease Arrangements (Tables)                         HTML    290K 
42: R31         Inventories (Tables)                                HTML     61K 
43: R32         Borrowings (Tables)                                 HTML     82K 
44: R33         Condensed Consolidated Statements of Operations     HTML    136K 
                Supplemental Information (Tables)                                
45: R34         Condensed Consolidated Statements of Cash Flows     HTML    223K 
                Supplemental Information (Tables)                                
46: R35         Income Taxes (Tables)                               HTML    245K 
47: R36         Capital Stock and Reserves (Tables)                 HTML    387K 
48: R37         Revenue from Contracts with Customers (Tables)      HTML    956K 
49: R38         Segment Reporting (Tables)                          HTML    409K 
50: R39         Employees Pension and Postretirement Benefits       HTML     67K 
                (Tables)                                                         
51: R40         Financial Instruments (Tables)                      HTML    310K 
52: R41         Non-Controlling Interests (Tables)                  HTML     56K 
53: R42         Basis of Presentation - Additional Information      HTML     81K 
                (Details)                                                        
54: R43         Basis of Presentation - VIEs Total Assets and       HTML     55K 
                Liabilities (Details)                                            
55: R44         Impact of COVID-19 Pandemic - Additional            HTML     42K 
                Information (Details)                                            
56: R45         Acquisition - Additional Information (Details)      HTML     57K 
57: R46         Acquisition - Schedule of Subject to Revision Upon  HTML     70K 
                Completion of Valuation Procedures (Details)                     
58: R47         Receivables - Summary of Allowance For Credit       HTML     57K 
                Losses Related to Accounts Receivable (Details)                  
59: R48         Receivables - Additional Information (Details)      HTML     67K 
60: R49         Receivables - Schedule of Financing Receivables     HTML     63K 
                (Details)                                                        
61: R50         Receivables - Schedule of Weighted-average          HTML     43K 
                Remaining Lease Term and Weighted-average Interest               
                Rate (Details)                                                   
62: R51         Receivables - Schedule of Net Investment In Leases  HTML     61K 
                by Credit Quality Indicator (Details)                            
63: R52         Receivables - Schedule of Financed Sale             HTML     77K 
                Receivables by Credit Quality Indicator (Details)                
64: R53         Receivables - Schedule of Aging Analysis for Net    HTML     79K 
                Investment in Leases and Financed Sale Receivables               
                (Details)                                                        
65: R54         Receivables - Schedule of Net Investment in Leases  HTML    100K 
                and Financed Sale Receivables with Billed Amounts                
                Past Due Continues to Accrue Finance Income                      
                (Details)                                                        
66: R55         Receivables - Schedule of Net Investment in Leases  HTML     48K 
                and Financed Sale Receivables on Nonaccrual Status               
                (Details)                                                        
67: R56         Receivables - Summary of Allowance for Credit       HTML     51K 
                Losses Related to Net Investment in Leases and                   
                Financed Sale Receivables (Details)                              
68: R57         Receivables - Summary of Allowance For Credit       HTML     43K 
                Losses Related to Variable Consideration                         
                Receivables (Details)                                            
69: R58         Lease Arrangements - Additional Information         HTML     64K 
                (Details)                                                        
70: R59         Lease Arrangements - Components of Operating Lease  HTML     50K 
                Expense (Details)                                                
71: R60         Lease Arrangements - Supplemental Cash and          HTML     47K 
                Non-Cash Flow Information Related to Leases                      
                (Details)                                                        
72: R61         Lease Arrangements - Lessee Operating Lease         HTML     54K 
                Balance Sheet Amounts and Lines (Details)                        
73: R62         Lease Arrangements - Lessee Operating Lease         HTML     37K 
                Balance Sheet Amounts and Lines (Parenthetical)                  
                (Details)                                                        
74: R63         Lease Arrangements - Lessee Leases Weighted         HTML     47K 
                Average Remaining Lease Term and Weighted Average                
                Interest Rate (Details)                                          
75: R64         Lease Arrangements - Lessee Operating and Finance   HTML     73K 
                Lease, Maturity (Details)                                        
76: R65         Lease Arrangements - Schedule of Maturities of      HTML     58K 
                Lease Receivables (Details)                                      
77: R66         Inventories - Inventories (Details)                 HTML     43K 
78: R67         Inventories - Additional Information (Details)      HTML     50K 
79: R68         Borrowings - Revolving Credit Facility Borrowings,  HTML     52K 
                Net (Details)                                                    
80: R69         Borrowings - Additional Information (Details)       HTML    241K 
81: R70         Borrowings - Summary of Convertible Notes, Net      HTML     44K 
                (Details)                                                        
82: R71         Commitments, Contingencies and Guarantees -         HTML     71K 
                Additional Information (Details)                                 
83: R72         Condensed Consolidated Statements of Operations     HTML     51K 
                Supplemental Information - Summary of Selling                    
                Expenses, Including Sales Commissions and Other                  
                Selling Expenses (Details)                                       
84: R73         Condensed Consolidated Statements of Operations     HTML     75K 
                Supplemental Information - Additional Information                
                (Details)                                                        
85: R74         Condensed Consolidated Statements of Cash Flows     HTML     52K 
                Supplemental Information - Summary of Changes in                 
                Other Operating Assets and Liabilities (Details)                 
86: R75         Condensed Consolidated Statements of Cash Flows     HTML     55K 
                Supplemental Information - Summary of Depreciation               
                and Amortization (Details)                                       
87: R76         Condensed Consolidated Statements of Cash Flows     HTML     39K 
                Supplemental Information - Summary of Depreciation               
                and Amortization (Parenthetical) (Details)                       
88: R77         Condensed Consolidated Statements of Cash Flows     HTML     63K 
                Supplemental Information - Write-downs (Details)                 
89: R78         Condensed Consolidated Statements of Cash Flows     HTML     59K 
                Supplemental Information - Write-downs                           
                (Parenthetical) (Details)                                        
90: R79         Condensed Consolidated Statements of Cash Flows     HTML     47K 
                Supplemental Information - Significant Non-cash                  
                Investing Activities - (Details)                                 
91: R80         Condensed Consolidated Statements of Cash Flows     HTML     38K 
                Supplemental Information - Significant Non-cash                  
                Investing Activities (Parenthetical) (Details)                   
92: R81         Condensed Consolidated Statements of Cash Flows     HTML     47K 
                -Supplemental Information - Additional Information               
                (Details)                                                        
93: R82         Income Taxes - Additional Information (Details)     HTML     49K 
94: R83         Income Taxes - Schedule of Effective Tax Rates      HTML     80K 
                (Details)                                                        
95: R84         Income Taxes - Income Tax Expense in Other          HTML     50K 
                Comprehensive Loss (Details)                                     
96: R85         Capital Stock and Reserves - Additional             HTML    154K 
                Information (Details)                                            
97: R86         Capital Stock and Reserves - Stock Compensation     HTML     46K 
                (Details)                                                        
98: R87         Capital Stock and Reserves - Stock-based            HTML     53K 
                Compensation by Plan Type (Details)                              
99: R88         Capital Stock and Reserves - Schedule of            HTML     67K 
                Share-based Compensation, Stock Options, Activity                
                (Details)                                                        
100: R89         Capital Stock and Reserves - Restricted Stock       HTML     58K  
                Units Activity under the IMAX LTIP (Details)                     
101: R90         Capital Stock and Reserves - Performance Stock      HTML     53K  
                Units Activity under the IMAX LTIP (Details)                     
102: R91         Capital Stock and Reserves - Basic and Diluted      HTML     44K  
                Per-share Computations (Details)                                 
103: R92         Revenue from Contracts with Customers -             HTML    200K  
                Disaggregation of Revenue by Segment (Details)                   
104: R93         Revenue from Contracts with Customers - Additional  HTML     39K  
                Information (Details)                                            
105: R94         Segment Reporting - Additional Information          HTML     40K  
                (Details)                                                        
106: R95         Segment Reporting - Segment Reporting Information   HTML    103K  
                by Category and Reportable Segment (Details)                     
107: R96         Segment Reporting - Segment Reporting Information   HTML     38K  
                by Category and Reportable Segment (Parenthetical)               
                (Details)                                                        
108: R97         Segment Reporting - Summary of Revenues By          HTML     70K  
                Geographic Area (Details)                                        
109: R98         Segment Reporting - Summary of Revenues By          HTML     42K  
                Geographic Area (Parenthetical) (Details)                        
110: R99         Employees Pension and Postretirement Benefits -     HTML     95K  
                Additional Information (Details)                                 
111: R100        Employee's Pension and Postretirement Benefits -    HTML     45K  
                Amounts Accrued and Unfunded Status (Details)                    
112: R101        Financial Instruments - Additional Information      HTML     85K  
                (Details)                                                        
113: R102        Financial Instruments - Fair Value of Financial     HTML     72K  
                Instruments (Details)                                            
114: R103        Financial Instruments - Notional Amount of          HTML     41K  
                Derivative (Details)                                             
115: R104        Financial Instruments - Fair Value of Foreign       HTML     49K  
                Exchange Contracts (Details)                                     
116: R105        Financial Instruments - Derivatives in Foreign      HTML     48K  
                Currency Hedging Relationships (Details)                         
117: R106        Financial Instruments - Non Designated Derivatives  HTML     42K  
                in Foreign Currency Relationships (Details)                      
118: R107        Non-Controlling Interests - Additional Information  HTML     69K  
                (Details)                                                        
119: R108        Non-Controlling Interests - Summary of Movement of  HTML     45K  
                the Non-controlling Interest in Temporary Equity                 
                Related to Original Film Fund (Details)                          
122: XML         IDEA XML File -- Filing Summary                      XML    242K  
120: XML         XBRL Instance -- imax-20220930_htm                   XML  11.32M  
121: EXCEL       IDEA Workbook of Financial Reports                  XLSX    298K  
11: EX-101.CAL  XBRL Calculations -- imax-20220930_cal               XML    344K 
 8: EX-101.DEF  XBRL Definitions -- imax-20220930_def                XML   1.40M 
 9: EX-101.LAB  XBRL Labels -- imax-20220930_lab                     XML   2.47M 
10: EX-101.PRE  XBRL Presentations -- imax-20220930_pre              XML   1.86M 
 7: EX-101.SCH  XBRL Schema -- imax-20220930                         XSD    396K 
123: JSON        XBRL Instance as JSON Data -- MetaLinks              702±  1.15M  
124: ZIP         XBRL Zipped Folder -- 0000950170-22-020630-xbrl      Zip    812K

‘EX-31.1’   —   Certification — §302 – SOA’02

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

  EX-31.1  

IMAX CORPORATION

Exhibit 31.1

 

Certification Pursuant to Section 302 of the Sarbanes - Oxley Act of 2002

 

I, Richard L. Gelfond, certify that:

 

1.
I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 of the registrant, IMAX Corporation;

 

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.
The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.
The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date:

 

October 31, 2022

 

By:

 

/s/ Richard L. Gelfond

 

 

 

 

Name:

 

Richard L. Gelfond

 

 

 

 

Title:

 

Chief Executive Officer

 

 

 

 

 

 

 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/31/228-K
For Period end:9/30/22
 List all Filings 

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/24  Imax Corp.                        10-K       12/31/23  187:34M                                    Donnelley … Solutions/FA
 2/22/23  Imax Corp.                        10-K       12/31/22  186:49M                                    Donnelley … Solutions/FA
↑Top
Filing Submission 0000950170-22-020630   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sat., Apr. 27, 7:25:35.1pm ET